De-novo portal vein thrombosis in liver cirrhosis: Risk factors and correlation with the Model for End-stage Liver Disease scoring system

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 5, 2015, Pages 585-592

  Abdel Razik, Ahmed ^a   Mousa, Nasser ^a   Elhelaly, Rania ^a   Tawfik, Ahmed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Computed tomography portal angiography; Doppler ultrasonography; Portal vein thrombosis; Splenic thickening

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ANTINUCLEAR ANTIBODY; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CREATININE; D DIMER; DOUBLE STRANDED DNA ANTIBODY; FIBRINOGEN; GLUCOSE; HEMOGLOBIN; IMMUNOGLOBULIN G ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; BLOOD CELL COUNT; BLOOD FLOW VELOCITY; CHILD PUGH SCORE; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIABETES MELLITUS; DIGESTIVE ENDOSCOPE; DISEASE ASSOCIATION; DOPPLER FLOWMETER; ENDOSCOPY; ESOPHAGUS VARICES; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PARACENTESIS; PARTIAL THROMBOPLASTIN TIME; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RISK FACTOR; SPLENIC VEIN; SUPERIOR MESENTERIC VEIN; THICKNESS; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; UPPER GASTROINTESTINAL BLEEDING; VASCULAR PATENCY; VEIN DIAMETER; AGED; BLOOD; COMPLICATION; DOPPLER ULTRASONOGRAPHY; ECHOGRAPHY; END STAGE LIVER DISEASE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOSIS;

AGED; BLOOD FLOW VELOCITY; DIABETES MELLITUS; END STAGE LIVER DISEASE; FEMALE; HEMOGLOBINS; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PLATELET COUNT; PORTAL SYSTEM; PORTAL VEIN; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPLENIC VEIN; THROMBOSIS; ULTRASONOGRAPHY, DOPPLER;

EID: 84927158301     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000325     Document Type: Article

References (43)

1. Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: a review. Am J Med 1992; 92:173-182.
2. Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006; 12:2115-2119.
3. Charco R, Fuster J, Fondevila C, Ferrer J, Mans E, García-Valdecasas JC. Portal vein thrombosis in liver transplantation. Transplant Proc 2005; 37:3904-3905.
4. De Leve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49:1729-1764.
5. Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 2005; 21:1-9.
6. Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37:463-470.
7. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000; 31:345-348.
8. Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992; 16:1195-1198.
9. Leebeek FW, Smalberg JH, Janssen HL. Prothrombotic disorders in abdominal vein thrombosis. Neth J Med 2012; 70:400-405.
10. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
11. Sabbà C, Merkel C, Zoli M, Ferraioli G, Gaiani S, Sacerdoti D, Bolondi L. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995; 21:428-433.
12. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51:682-689.
13. Bosch J, Reverter JC. The coagulopathy of cirrhosis: myth or reality? Hepatology 2005; 41:434-435.
14. Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005; 17:745-751.
15. Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M, et al. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006; 26:512-519.
16. Fimognari FL, Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med 2008; 3:213-218.
17. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40:736-741.
18. Chen H, Trilok G, Wang F, Qi X, Xiao J, Yang C. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors. Indian J Med Res 2014; 139:260-266.
19. Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Kearon C, et al. HOPE-2 investigators. Venous thromboembolism in association with features of the metabolic syndrome. QJM 2007; 100:679-684.
20. Gîrleanu I, Trifan A, Cojocariu C, Sîngeap AM, Sfarti C, Stanciu C. The risk of thrombotic events in patients with liver cirrhosis. Rev Med Chir Soc Med Nat Iasi 2012; 116:991-996.
21. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001; 15:44-54.
22. Reverter JL, Reverter JC, Tàssies D, Rius F, Monteagudo J, Rubiés-Prat J, et al. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy:aprospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus. Am J Hematol 1997; 56:93-99.
23. Carr ME Jr, Alving BM. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul Fibrinolysis 1995; 6:567-573.
24. Hirohata Y, Murata A, Abe S, Otsuki M. Portal vein thrombosis associated with antiphospholipid syndrome. J Gastroenterol 2001;36:574-578.
25. Ushitora Y, Tashiro H, Takahashi S, Amano H, Oshita A, Kobayashi T, et al. Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 2011; 28:9-14.
26. Abdel-Razik A, Eldars W, Rizk E. Platelet indices and inflammatory markers as diagnostic predictors for ascitic fluid infection. Eur J Gastroenterol Hepatol 2014; 26:1342-1347.
27. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98:2720-2725.
28. Van der Loo B, Martin JF. A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol 1999; 19:672-679.
29. Kilciler G, Genc H, Tapan S, Ors F, Kara M, Karadurmus N, et al. Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Ups J Med Sci 2010; 115:253-259.
30. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size and age determine platelet function independently. Blood 1984; 63:1372-1375.
31. Beyazit Y, Sayilir A, Torun S, Suvak B, Yesil Y, Purnak T, et al. Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis. Clin Res Hepatol Gastroenterol 2012; 36:162-168.
32. Byers JM III. Rudolf Virchow - father of cellular pathology. Am J Clin Pathol 1989; 92 (Suppl 1):S2-S8.
33. Li MX, Zhang XF, Liu ZW, Lv Y. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 2013; 12:512-519.
34. Zoli M, Iervese T, Merkel C, Bianchi G, Magalotti D, Marchesini G, et al. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol 1993; 17:56-61.
35. Amitrano L, Guardascione MA, Ames PR. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clin Lab 2007; 53:583-589.
36. Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol 1992; 16:298-303.
37. Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis 2002; 34:144-150.
38. Al Ghumlas AK, Abdel Gader AG, Al Faleh FZ. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests? Blood Coagul Fibrinolysis 2005; 16:329-335.
39. Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001; 49:720-724.
40. Yerdel MA, Gunson B, Mirza D, Karayalçin K, Olliff S, Buckels J, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000; 69:1873-1881.
41. Rodriguez-Castro KI, Simioni P, Burra P, Senzolo M. Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis. Liver Int 2012; 32:1465-1476.
42. Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012; 143:1253.e4-1260.e4.
43. Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010; 44:448-451.